Trafficking and differentiation of mesenchymal stem cells

The DeWitt Daughtry Family Department of Surgery, Leonard M. Miller School of Medicine, University of MiamiJackson Memorial Medical Center, Miami, FL 33136, USA.
Journal of Cellular Biochemistry (Impact Factor: 3.37). 04/2009; 106(6):984-91. DOI: 10.1002/jcb.22091
Source: PubMed

ABSTRACT Mesenchymal stem cells (MSCs) are a heterogeneous population of stem/progenitor cells with pluripotent capacity to differentiate into mesodermal and non-mesodermal cell lineages, including osteocytes, adipocytes, chondrocytes, myocytes, cardiomyocytes, fibroblasts, myofibroblasts, epithelial cells, and neurons. MSCs reside primarily in the bone marrow, but also exist in other sites such as adipose tissue, peripheral blood, cord blood, liver, and fetal tissues. When stimulated by specific signals, these cells can be released from their niche in the bone marrow into circulation and recruited to the target tissues where they undergo in situ differentiation and contribute to tissue regeneration and homeostasis. Several characteristics of MSCs, such as the potential to differentiate into multiple lineages and the ability to be expanded ex vivo while retaining their original lineage differentiation commitment, make these cells very interesting targets for potential therapeutic use in regenerative medicine and tissue engineering. The feasibility for transplantation of primary or engineered MSCs as cell-based therapy has been demonstrated. In this review, we summarize the current knowledge on the signals that control trafficking and differentiation of MSCs.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In this work, we investigated the bioactivity of anodic oxide coatings on Ti-13Nb-13Zr alloy by plasma electrolytic oxidation (PEO) in solutions containing Ca and P. The bioactive properties of the films were determined by immersion in simulated body fluid (SBF), and their biocompatibility was examined using adult human bone marrow derived mesenchymal stem cells (hBMSCs). The oxide layers were characterised based on their surface morphology (SEM, AFM, profilometry) as well as on their chemical and phase compositions (EDX, XRF, XRD, XPS). We report that anodic oxidation of Ti-13Nb-13Zr led to the development of relatively thick anodic oxide films that were enriched in Ca and P in the form of phosphate compounds. Furthermore, the treatment generated rough surfaces with a significant amount of open pores. The surfaces were essentially amorphous, with small amounts of crystalline phases (anatase and rutile) being observed, depending on the PEO process parameters. SBF soaking led to the precipitation of small crystals after one week of experiment. During culturing of hBMSCs on the bioactive Ti-13Nb-13Zr surfaces the differentiation of human mesenchymal stem cells toward osteoblasts was promoted, which indicated a potential of the modified materials to improve implant osseointegration. Copyright © 2014 Elsevier B.V. All rights reserved.
    Materials Science and Engineering C 04/2015; 49. DOI:10.1016/j.msec.2014.12.073 · 2.74 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A major challenge in cartilage repair is the lack of chondrogenic cells migrating from healthy tissue into damaged areas and strategies to promote this should be developed. The aim of this study was to evaluate the effect of peripheral blood derived mononuclear cell (PBMC) stimulation on mesenchymal stromal cells (MSCs) derived from the infrapatellar fat pad of human OA knee. Cell migration was measured using an xCELLigence electronic migration chamber system in combination with scratch assays. Gene expression was quantified with stem cell PCR arrays and validated using quantitative real-time PCR (rtPCR). In both migration assays PBMCs increased MSC migration by comparison to control. In scratch assay the wound closure was 55% higher after 3 hours in the PBMC stimulated test group (P = 0.002), migration rate was 9 times faster (P = 0.008), and total MSC migration was 25 times higher after 24 hours (P = 0.014). Analysis of MSCs by PCR array demonstrated that PBMCs induced the upregulation of genes associated with chondrogenic differentiation over 15-fold. In conclusion, PBMCs increase both MSC migration and differentiation suggesting that they are an ideal candidate for inclusion in regenerative medicine therapies aimed at cartilage repair.
    Stem cell International 01/2015; Article ID 323454. DOI:10.1155/2015/323454 · 2.81 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract: Dental pulp stem cells (DPSCs) share similar gene expression profiles and differentiation capabilities to that of bone marrow derived stem cells (BMSCs). DPSCs are potentially superior to other types of adult stem cell, as teeth are easy to access and are extracted routinely throughout life. The permanent (4 premolars and 2 third molars) and deciduous (4 first molars) teeth were removed using local anesthesia. The dental pulps were exposed using a sterile hand-held low-speed disc and the teeth were split using a chisel along the groove. The pulps of the teeth were then extracted with endodontic files or pansies and digested in collagenase type I and dispase. The resultant cell suspensions from each tooth were then centrifuged, cultured and evaluated by flow cytometry. The DPSCs from both permanent and deciduous teeth proliferated rapidly whilst attaching to the floor of the flask with a spindleshaped morphology. More than 80% of the cell population exhibited the expression of surface antigens known to be found on mesenchymal lineages such as CD105, CD90, CD166, and CD73, whilst only less than 4% expressed endothelial-hematopoietic epitopes including, CD11b, CD34, CD133, CD64, CD106, CD31 and CD45. DPSCs and BMSSCs, which can differentiate into multiple mesenchymal cell lineages, are putative candidate cells for tooth and bone-tissue engineering, respectively. Considering the results, dental pulp stem cells can be thought of as being part of the MSC population and may be considered suitable for use in regenerative medicine.


1 Download